Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Clinical trial NCT06916494 · RECRUITING
Trial details
- NCT number
- NCT06916494
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-01-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.